3-hydroxyephedrine has been researched along with Cardiomyopathies in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Beanlands, RSB; Canty, JM; deKemp, RA; Fallavollita, JA; Kaps, N; Lavallee, A; Renaud, JM; Rotstein, B; Wang, JZ; Zelt, JGE | 1 |
Beanlands, RSB; deKemp, RA; Garrard, L; Hadizad, T; Mielniczuk, LM; Orlandi, C; Robinson, S; Walter, O; Zelt, JGE | 1 |
Cain, ME | 1 |
Amanullah, A; Gupta, S | 1 |
de Haan, S; Greuter, H; Harms, HJ; Hsieh, YL; Huisman, MC; Knaapen, P; Lammertsma, AA; Lubberink, M; Rijnierse, MT; Schuit, RC | 1 |
1 review(s) available for 3-hydroxyephedrine and Cardiomyopathies
Article | Year |
---|---|
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
1 trial(s) available for 3-hydroxyephedrine and Cardiomyopathies
Article | Year |
---|---|
Noninvasive Quantification of Myocardial 11C-Meta-Hydroxyephedrine Kinetics.
Topics: Aged; Aged, 80 and over; Algorithms; Cardiomyopathies; Computer Simulation; Ephedrine; Heart; Humans; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Middle Aged; Models, Cardiovascular; Myocardium; Organ Specificity; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2016 |
3 other study(ies) available for 3-hydroxyephedrine and Cardiomyopathies
Article | Year |
---|---|
Does quantification of [
Topics: Ammonia; Cardiomyopathies; Death, Sudden, Cardiac; Ephedrine; Heart; Humans; Kinetics; Myocardial Ischemia; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left | 2022 |
PET imaging of sympathetic innervation with [
Topics: Aged; Cardiomyopathies; Ephedrine; Fluorobenzenes; Guanidines; Humans; Male; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Risk; ST Elevation Myocardial Infarction; Sympathetic Nervous System | 2019 |
Impact of denervated myocardium on improving risk stratification for sudden cardiac death.
Topics: Aged; Cardiomyopathies; Chi-Square Distribution; Death, Sudden, Cardiac; Echocardiography; Ephedrine; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Stunning; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Tachycardia, Ventricular; Tissue Survival; Ventricular Fibrillation; Ventricular Function, Left | 2014 |